By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Science Briefing
  • Medicine
  • Biology
  • Engineering
  • Environment
  • More
    • Dentistry
    • Chemistry
    • Physics
    • Agriculture
    • Business
    • Computer Science
    • Energy
    • Materials Science
    • Mathematics
    • Politics
    • Social Sciences
Notification
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Personalize
Science BriefingScience Briefing
Font ResizerAa
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Search
  • Quick Access
    • Home
    • Contact Us
    • Blog Index
    • History
    • My Saves
    • My Interests
    • My Feed
  • Categories
    • Business
    • Politics
    • Medicine
    • Biology

Top Stories

Explore the latest updated news!

Today’s Public Health Science Briefing | April 21st 2026, 9:00:12 am

Today’s Political Science Science Briefing | April 21st 2026, 9:00:12 am

Today’s Neurology Science Briefing | April 21st 2026, 9:00:12 am

Stay Connected

Find us on socials
248.1KFollowersLike
61.1KFollowersFollow
165KSubscribersSubscribe
Made by ThemeRuby using the Foxiz theme. Powered by WordPress

Home - Emergency Medicine - A Systematic Review Charts the Course for Prehospital Sedation in Acute Agitation

Emergency Medicine

A Systematic Review Charts the Course for Prehospital Sedation in Acute Agitation

Last updated: February 28, 2026 3:29 am
By
Science Briefing
ByScience Briefing
Science Communicator
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Follow:
No Comments
Share
SHARE

A Systematic Review Charts the Course for Prehospital Sedation in Acute Agitation

A systematic review published in the Emergency Medicine Journal synthesizes evidence on managing acute behavioural disturbance (ABD) in the prehospital setting. Analyzing 42 studies, the research found ketamine to be the most effective agent for sedation, achieving adequate sedation in 79–98% of patients, though dosing regimens varied. Midazolam was associated with a higher incidence of side effects, particularly respiratory complications, while droperidol showed no increased mortality or concerning QT interval effects. The review underscores that current evidence is limited in quality, highlighting an urgent need for standardized protocols and higher-quality research to optimize care for this high-risk population.

Why it might matter to you: For emergency clinicians, this review provides a critical, evidence-based comparison of pharmacological options for managing severe agitation, a common and dangerous presentation. It directly informs rapid sequence induction and sedation strategies in uncontrolled prehospital environments. The findings can guide protocol development for mass casualty or disaster scenarios where resource allocation and effective chemical restraint are paramount.

Source →

Stay curious. Stay informed — with Science Briefing.

Always double check the original article for accuracy.

- Advertisement -

Feedback

Share This Article
Facebook Flipboard Pinterest Whatsapp Whatsapp LinkedIn Tumblr Reddit Telegram Threads Bluesky Email Copy Link Print
Share
ByScience Briefing
Science Communicator
Follow:
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Previous Article La urgencia de la equidad: transformar la atención de emergencia en una herramienta de salud pública
Next Article Blood Lactate: A New Biomarker for Prognosis in Neuromuscular Disease
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Stories

Uncover the stories that related to the post!

How Trial Design Influences Outcomes in Acute Brain Injury Research

The February 2026 Issue of Academic Emergency Medicine

Organoid Models Reveal Hepatitis E’s Systemic Threat

The Hidden Cost of Routine Care: A Closer Look at Hospital Phlebotomy

A Novel Target for Stabilizing Microvasculature in Sickle Cell Crisis

Immune Checkpoint Inhibitors Show Survival Benefit in High-Risk Lung Cancer Patients

A new link between heart failure and diabetes emerges

Securitizing the Future of Orphan Disease Therapies

Show More

Science Briefing delivers personalized, reliable summaries of new scientific papers—tailored to your field and interests—so you can stay informed without doing the heavy reading.

Science Briefing
  • Categories:
  • Medicine
  • Biology
  • Social Sciences
  • Gastroenterology
  • Surgery
  • Natural Language Processing
  • Energy
  • Chemistry
  • Engineering
  • Neurology

Quick Links

  • My Feed
  • My Interests
  • History
  • My Saves

About US

  • Adverts
  • Our Jobs
  • Term of Use

ScienceBriefing.com, All rights reserved.

Personalize you Briefings
To Receive Instant, personalized science updates—only on the discoveries that matter to you.
Please enable JavaScript in your browser to complete this form.
Loading
Zero Spam, Cancel, Upgrade or downgrade anytime!
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?